Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Legislation 2005: OTCs Seek A Tax Break, Pseudoephedrine May Take A Hit

This article was originally published in The Tan Sheet

Executive Summary

Efforts to classify OTC drugs as tax deductible may be well-positioned for action in the 109th Congress following a cost analysis by the House Joint Committee on Taxation

You may also be interested in...



Flexible Spending Rollover Would Hamper HSA Growth – Treasury

A Treasury Department decision to reject a proposed rollover of flexible spending account funds underscores the Bush Administration's commitment to promoting health savings accounts

OTCs Would Be Tax Deductible Under House Bill; Supplement Status Unclear

A bill to make nonprescription drugs qualify as deductible medical expenses would make the law evenhanded to consumers using OTCs for chronic conditions, sponsor Rep. Jim DeMint (R-S.C.) says

Judge Orders FDA, Food Safety Group To Set FSMA Implementation Date

FDA’s delays in implementing the Food Safety Modernization Act violated FSMA and the Administrative Procedures Act, a federal court finds in an April 22 order. The agency must meet with plaintiff Center for Food Safety to agree on new implementation deadlines by May 20.

Topics

UsernamePublicRestriction

Register

MT142313

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel